The markets opened lower with the Dow slipping 14 points to 22,144 after North Korea threatened to sink Japan. Nasdaq dropped 21 points to 6,439.
On the upside
Halozyme Therapeutics (Nasdaq: HALO) licensed its Enhanze technology to Bristol-Myers Squibb (NYSE: BMY) for $105 million upfront and Roche for $30 million upfront.
Autoliv (NYSE: ALV) may split itself into two publicly traded companies.
United Natural Foods (Nasdaq: UNFI) reported higher fourth quarter earnings that topped analyst estimates.
On the downside
The Federal Trade Commission has opened an investigation into Equifax (NYSE: EFX) over its massive data breach.
Profit taking weighed down shares of Opko Health (Nasdaq: OPK).
US Foods Holding (NYSE: USFD) announced a secondary offering of 40 million common shares.
In the broad market, declining issues outpaced advancers by a margin of nearly 9 to 8 on the NYSE and by 4 to 3 on Nasdaq. The broader S&P 500 lost 4 points to 2,494. Bitcoin collapsed $334 to $3,550.
